Skip to main content

Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes, genes.
Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in cancer.
As the discovery, identification, characterization and validation of novel human drug targets for anti-cancer drug discovery continues to grow; this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.

Publisher: Bentham Science Publishers

Volume 5, Number 4, June 2005

Review article

Antiangiogenic Therapy in Acute Myelogenous Leukemia: Targeting of Vascular Endothelial Growth Factor and Interleukin 8 as Possible Antileukemic Strategies
pp. 229-248(20)
Authors: Hatfield, Kimberley J.; Olsnes, Astrid M.; Gjertsen, Bjorn T.; Bruserud, Oystein


Squalamine: A Polyvalent Drug of the Future?
pp. 267-272(6)
Authors: Brunel, Jean M.; Salmi, Chanaz; Loncle, Celine; Vidal, Nicolas; Letourneux, Yves


Matrix Metalloproteinase Inhibitors as Anticancer Therapeutics
pp. 285-298(14)
Authors: Mannello, F.; Tonti, G.; Papa, S.


The Anti-Tumor Effect and Mechanisms of Action of Penta-Acetyl Geniposide
pp. 299-305(7)
Authors: Peng, C. H.; Huang, C. N.; Wang, C. J.


Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more